APA (7th ed.) Citation

Bölek, H., Yazgan, S. C., Yekedüz, E., & Ürün, Y. (2026). Prognostic Impact of Intraductal Carcinoma in Patients with Metastatic Prostate Cancer Treated with Abiraterone Acetate or Enzalutamide. Bulletin of Urooncology, 25(1), 1. https://doi.org/10.4274/uob.galenos.2026.2025.12.1

Chicago Style (17th ed.) Citation

Bölek, Hatice, Satı Coşkun Yazgan, Emre Yekedüz, and Yüksel Ürün. "Prognostic Impact of Intraductal Carcinoma in Patients with Metastatic Prostate Cancer Treated with Abiraterone Acetate or Enzalutamide." Bulletin of Urooncology 25, no. 1 (2026): 1. https://doi.org/10.4274/uob.galenos.2026.2025.12.1.

MLA (9th ed.) Citation

Bölek, Hatice, et al. "Prognostic Impact of Intraductal Carcinoma in Patients with Metastatic Prostate Cancer Treated with Abiraterone Acetate or Enzalutamide." Bulletin of Urooncology, vol. 25, no. 1, 2026, p. 1, https://doi.org/10.4274/uob.galenos.2026.2025.12.1.